The cross-over trial: A subtle knife

Significance

Volumn 5, Issue 3, 2008, Pages 135-137

  Jones, Byron ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50849109200     PISSN: 17409705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1740-9713.2008.00312.x     Document Type: Article

References (8)

1. Pullman, P. (2007) The Subtle Knife. London : Scholastic.
2. Jones, B. and Kenward, M. G. (2003) Design and Analysis of Cross-over Trials, 2nd edn. Boca Raton, FL : Chapman and Hall/CRC.
3. Grizzle, J. E. (1965) The two-period changeover design and its use in clinical trials. Biometrics, 21, 467 480.
4. Freeman, P. (1989) The performance of the two-stage analysis of two treatment, two period crossover trials. Statistics in Medicine, 8, 1421 1432.
5. Patterson. S. D. and Jones, B. (2006) Bioequivalence and Statistics in Clinical Pharmacology. Boca Raton, FL : Chapman and Hall/CRC.
6. Senn, S. (2004). When is a drug not a drug Significance, 1, 159 161.
7. James, I. M., Griffith, D. N. W., Pearson, R. M. and Newbury, P. (1977). Effect of oxprenenolol on stage-fright in musicians. Lancet, 2, 952 954.
8. Greene, M. K., Kerr, A. M., Mclntosh, I. B. and Prescott, R. J. (1981) Acetazolamide in prevention of acute mountain sickness: a double-blind controlled cross-over study. British Medical Journal, 28, 811 813.